We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Wondfo Exhibits Newly-Launched Time-Resolved Fluorescence Immunoassay Analyzers

By HospiMedica International staff writers
Posted on 15 Aug 2023
Print article
Image: The FDA-cleared POC fentanyl urine detection test runs on the RYAN immunofluorescence analyzer (Photo courtesy of Carolina Liquid Chemistries)
Image: The FDA-cleared POC fentanyl urine detection test runs on the RYAN immunofluorescence analyzer (Photo courtesy of Carolina Liquid Chemistries)

Wondfo (Guangzhou, China) is providing a glimpse of its several newly-launched products alongside its flagship products at AACC 2023.

Wondfo's flagship products being highlighted at the show include the Finecare FIA Meters (FS-114/FS-205), Accre CLIA Analyzer (A90), and Blood Gas Analyzer (BGA-102). The Finecare FIA Meter Ⅱ Plus SE (FS-114) is intended for use by healthcare professionals to improve diagnosis and monitoring of various conditions, including COVID-19, diabetes, renal injury, cardiovascular disease, pregnancy, inflammation, tumor, etc. The Finecare FIA Meter III Plus (FS-205) is a fluorescence immunochromatographic semi-automatic analyzing system with internal temperature control. It can test 20 items at the same time and help diagnose conditions such as infection, diabetes, cardiovascular diseases, renal injury, hormone, etc.

Accre 90 is a compact automatic bench-top chemiluminescence immunoassay (CLIA) analyzer. With a single-dose reagent cartridge, it allows 600 days MTBF, requiring no extra consumables. It offers both simple operation, and a reliable calibration & quality control system. Wondfo's Blood Gas Analyzer (BGA-102) is used with its blood gas test cartridge (electrochemistry) to measure a patient's pH balance, pCO2, pO2, Na+, K+, Ca2+, Cl–, Hct, Lac, and Glu. Among its newly-launched products highlighted at AACC 2023 were the new FS-1000 and FS-2000 fluorescence immunoassay analyzers which offer improved specificity, sensitivity, repeatability, stability, and faster results in 3-8 minutes.

At the Wondfo AACC 2023 booth, Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) is showcasing the RYAN, the "next generation" of fentanyl testing. RYAN is a portable fluorescence instrument that can be used in a laboratory or point-of-care setting with the Fentanyl Urine Detection Kit which is the first ever FDA-cleared and CLIA-categorized point-of-care fentanyl test. This fluorescence immunoassay is intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.

Related Links:
Wondfo 
Carolina Liquid Chemistries

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.